Marrone Bio Innovations Q3 EPS $(0.14) Misses $(0.05) Estimate, Sales $6.966M Beat $6.95M Estimate

Marrone Bio Innovations (NASDAQ:MBII) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.05) by 180 percent. This is a 250 percent decrease over losses of $(0.04) per share

Benzinga · 11/12/2019 21:26

Marrone Bio Innovations (NASDAQ:MBII) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.05) by 180 percent. This is a 250 percent decrease over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $6.966 million which beat the analyst consensus estimate of $6.95 million by 0.23 percent. This is a 28.41 percent increase over sales of $5.425 million the same period last year.